BBIO
BridgeBio Pharma, Inc.$75.80+0.85 (+1.13%)Prev Close$74.95·MCap$14.65B·P/E—·Vol1.29M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
45
$127.69M
◆
Net Activity
Net Seller
$127.69M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at BridgeBio Pharma, Inc. (BBIO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 45 insider sales totaling $127.69M. The most recent insider transaction was by Kumar Neil (director, officer: Chief Executive Officer), who sold $690.8K worth of shares on Sep 21, 2026. BridgeBio Pharma, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $14.65B.
BBIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 10,000 | $69.08 | $690.8K | 496,965 |
| Aug 20, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 44,980 | $82.86 | $3.73M | 507,586 |
| Aug 3, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $80.06 | $160.1K | 127,401 |
| Jul 13, 2026 | Ellis Andrea | director | Sell | 17,167 | $84.00 | $1.44M | 22,579-43% |
| Jul 13, 2026 | Cook Jennifer E. | director | Sell | 148,589 | $88.54 | $13.16M | 120,805-55% |
| Jun 24, 2026 | Valantine Hannah | director | Sell | 5,004 | $68.25 | $341.5K | 11,455-30% |
| Jun 24, 2026 | Cook Jennifer E. | director | Sell | 39,363 | $69.92 | $2.75M | 8,383-82% |
| Jun 17, 2026 | Cook Jennifer E. | director | Sell | 90,240 | $66.62 | $6.01M | 8,092-92% |
| Jun 8, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 51,563 | $67.71 | $3.49M | 4,356,247 |
| May 26, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 26,103 | $69.44 | $1.81M | 267,174 |
| May 19, 2026 | Scott Randal W. | director | Sell | 10,000 | $67.15 | $671.5K | 15,389-39% |
| May 19, 2026 | Trimarchi Thomas | officer: President and CFO | Sell | 13,651 | $65.08 | $888.4K | 362,389 |
| May 11, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 67,833 | $67.37 | $4.57M | 4,387,230 |
| May 4, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $71.58 | $143.2K | 134,115 |
| Apr 13, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 60,000 | $74.61 | $4.48M | 4,431,375 |
| Mar 16, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 79,700 | $68.76 | $5.48M | 4,464,562 |
| Mar 12, 2026 | Valantine Hannah | director | Sell | 8,671 | $72.00 | $624.3K | 7,465-54% |
| Mar 6, 2026 | Ellis Andrea | director | Sell | 64,921 | $64.87 | $4.21M | 18,589-78% |
| Mar 3, 2026 | Valantine Hannah | director | Sell | 25,484 | $67.41 | $1.72M | 18,365-58% |
| Feb 27, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $66.00 | $132.0K | 121,945 |
| Feb 23, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 28,053 | $71.39 | $2.00M | 243,581 |
| Feb 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 28,053 | $71.39 | $2.00M | 0 |
| Feb 18, 2026 | Scott Randal W. | director | Sell | 10,000 | $75.46 | $754.6K | 19,689-34% |
| Feb 18, 2026 | Trimarchi Thomas | President and CFO | Sell | 45,819 | $74.93 | $3.43M | 336,785 |
| Feb 17, 2026 | Scott Randal W. | Director | Sell | 10,000 | $75.46 | $754.6K | 0 |
| Feb 16, 2026 | Apuli Maricel | Chief Accounting Officer | Sell | 4,859 | $75.15 | $365.2K | 0 |
| Feb 16, 2026 | Kumar Neil | Chief Executive Officer | Sell | 30,970 | $75.25 | $2.33M | 0 |
| Feb 12, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 80,000 | $71.86 | $5.75M | 4,504,407 |
| Feb 10, 2026 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $71.86 | $5.75M | 0 |
| Jan 12, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 80,000 | $75.54 | $6.04M | 4,546,882 |
| Jan 8, 2026 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $75.54 | $6.04M | 0 |
| Dec 12, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 2,003 | $75.15 | $150.5K | 0 |
| Dec 12, 2025 | Kumar Neil | Chief Executive Officer | Sell | 60,975 | $74.90 | $4.57M | 0 |
| Dec 12, 2025 | Trimarchi Thomas | President and CFO | Sell | 13,826 | $75.15 | $1.04M | 0 |
| Dec 8, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $74.26 | $148.5K | 0 |
| Dec 4, 2025 | Kumar Neil | Chief Executive Officer | Sell | 77,900 | $73.87 | $5.75M | 0 |
| Nov 20, 2025 | Kumar Neil | Chief Executive Officer | Sell | 26,156 | $65.84 | $1.72M | 0 |
| Nov 17, 2025 | Lo Andrew | Director | Sell | 95,599 | $66.11 | $6.32M | 0 |
| Nov 17, 2025 | Scott Randal W. | Director | Sell | 10,000 | $66.65 | $666.5K | 0 |
| Nov 16, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 4,781 | $66.39 | $317.4K | 0 |
| Nov 16, 2025 | Kumar Neil | Chief Executive Officer | Sell | 32,855 | $66.39 | $2.18M | 0 |
| Nov 16, 2025 | Trimarchi Thomas | President and CFO | Sell | 38,251 | $66.42 | $2.54M | 0 |
| Nov 12, 2025 | Valantine Hannah | Director | Sell | 25,484 | $66.07 | $1.68M | 0 |
| Nov 6, 2025 | DANIELS RONALD J | Director | Sell | 61,031 | $63.72 | $3.89M | 0 |
| Nov 6, 2025 | Kumar Neil | Chief Executive Officer | Sell | 79,900 | $62.29 | $4.98M | 0 |
| Oct 29, 2025 | MCCORMICK FRANK | Director | Sell | 198,359 | $66.58 | $13.21M | 0 |
| Oct 27, 2025 | MCCORMICK FRANK | Director | Sell | 1,641 | $65.00 | $106.7K | 0 |
| Oct 8, 2025 | Kumar Neil | Chief Executive Officer | Sell | 60,000 | $54.79 | $3.29M | 0 |
| Sep 5, 2025 | MCCORMICK FRANK | Director | Sell | 74,000 | $53.16 | $3.93M | 0 |
| Sep 4, 2025 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $52.20 | $4.18M | 0 |
Showing 1–50 of 159
1 / 4
BBIO Insider Buying Activity
The following table shows recent insider purchases of BridgeBio Pharma, Inc. (BBIO) stock reported via SEC Form 4 filings.
No insider buying activity found for BBIO in the last 12 months.
BBIO Insider Selling Activity
The following table shows recent insider sales of BridgeBio Pharma, Inc. (BBIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 10,000 | $69.08 | $690.8K | 496,965 |
| Aug 20, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 44,980 | $82.86 | $3.73M | 507,586 |
| Aug 3, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $80.06 | $160.1K | 127,401 |
| Jul 13, 2026 | Ellis Andrea | director | Sell | 17,167 | $84.00 | $1.44M | 22,579-43% |
| Jul 13, 2026 | Cook Jennifer E. | director | Sell | 148,589 | $88.54 | $13.16M | 120,805-55% |
| Jun 24, 2026 | Valantine Hannah | director | Sell | 5,004 | $68.25 | $341.5K | 11,455-30% |
| Jun 24, 2026 | Cook Jennifer E. | director | Sell | 39,363 | $69.92 | $2.75M | 8,383-82% |
| Jun 17, 2026 | Cook Jennifer E. | director | Sell | 90,240 | $66.62 | $6.01M | 8,092-92% |
| Jun 8, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 51,563 | $67.71 | $3.49M | 4,356,247 |
| May 26, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 26,103 | $69.44 | $1.81M | 267,174 |
| May 19, 2026 | Scott Randal W. | director | Sell | 10,000 | $67.15 | $671.5K | 15,389-39% |
| May 19, 2026 | Trimarchi Thomas | officer: President and CFO | Sell | 13,651 | $65.08 | $888.4K | 362,389 |
| May 11, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 67,833 | $67.37 | $4.57M | 4,387,230 |
| May 4, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $71.58 | $143.2K | 134,115 |
| Apr 13, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 60,000 | $74.61 | $4.48M | 4,431,375 |
| Mar 16, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 79,700 | $68.76 | $5.48M | 4,464,562 |
| Mar 12, 2026 | Valantine Hannah | director | Sell | 8,671 | $72.00 | $624.3K | 7,465-54% |
| Mar 6, 2026 | Ellis Andrea | director | Sell | 64,921 | $64.87 | $4.21M | 18,589-78% |
| Mar 3, 2026 | Valantine Hannah | director | Sell | 25,484 | $67.41 | $1.72M | 18,365-58% |
| Feb 27, 2026 | Apuli Maricel | officer: Chief Accounting Officer | Sell | 2,000 | $66.00 | $132.0K | 121,945 |
| Feb 23, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 28,053 | $71.39 | $2.00M | 243,581 |
| Feb 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 28,053 | $71.39 | $2.00M | 0 |
| Feb 18, 2026 | Scott Randal W. | director | Sell | 10,000 | $75.46 | $754.6K | 19,689-34% |
| Feb 18, 2026 | Trimarchi Thomas | President and CFO | Sell | 45,819 | $74.93 | $3.43M | 336,785 |
| Feb 17, 2026 | Scott Randal W. | Director | Sell | 10,000 | $75.46 | $754.6K | 0 |
| Feb 16, 2026 | Apuli Maricel | Chief Accounting Officer | Sell | 4,859 | $75.15 | $365.2K | 0 |
| Feb 16, 2026 | Kumar Neil | Chief Executive Officer | Sell | 30,970 | $75.25 | $2.33M | 0 |
| Feb 12, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 80,000 | $71.86 | $5.75M | 4,504,407 |
| Feb 10, 2026 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $71.86 | $5.75M | 0 |
| Jan 12, 2026 | Kumar Neil | director, officer: Chief Executive Officer | Sell | 80,000 | $75.54 | $6.04M | 4,546,882 |
| Jan 8, 2026 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $75.54 | $6.04M | 0 |
| Dec 12, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 2,003 | $75.15 | $150.5K | 0 |
| Dec 12, 2025 | Kumar Neil | Chief Executive Officer | Sell | 60,975 | $74.90 | $4.57M | 0 |
| Dec 12, 2025 | Trimarchi Thomas | President and CFO | Sell | 13,826 | $75.15 | $1.04M | 0 |
| Dec 8, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $74.26 | $148.5K | 0 |
| Dec 4, 2025 | Kumar Neil | Chief Executive Officer | Sell | 77,900 | $73.87 | $5.75M | 0 |
| Nov 20, 2025 | Kumar Neil | Chief Executive Officer | Sell | 26,156 | $65.84 | $1.72M | 0 |
| Nov 17, 2025 | Lo Andrew | Director | Sell | 95,599 | $66.11 | $6.32M | 0 |
| Nov 17, 2025 | Scott Randal W. | Director | Sell | 10,000 | $66.65 | $666.5K | 0 |
| Nov 16, 2025 | Apuli Maricel | Chief Accounting Officer | Sell | 4,781 | $66.39 | $317.4K | 0 |
| Nov 16, 2025 | Kumar Neil | Chief Executive Officer | Sell | 32,855 | $66.39 | $2.18M | 0 |
| Nov 16, 2025 | Trimarchi Thomas | President and CFO | Sell | 38,251 | $66.42 | $2.54M | 0 |
| Nov 12, 2025 | Valantine Hannah | Director | Sell | 25,484 | $66.07 | $1.68M | 0 |
| Nov 6, 2025 | DANIELS RONALD J | Director | Sell | 61,031 | $63.72 | $3.89M | 0 |
| Nov 6, 2025 | Kumar Neil | Chief Executive Officer | Sell | 79,900 | $62.29 | $4.98M | 0 |
| Oct 29, 2025 | MCCORMICK FRANK | Director | Sell | 198,359 | $66.58 | $13.21M | 0 |
| Oct 27, 2025 | MCCORMICK FRANK | Director | Sell | 1,641 | $65.00 | $106.7K | 0 |
| Oct 8, 2025 | Kumar Neil | Chief Executive Officer | Sell | 60,000 | $54.79 | $3.29M | 0 |
| Sep 5, 2025 | MCCORMICK FRANK | Director | Sell | 74,000 | $53.16 | $3.93M | 0 |
| Sep 4, 2025 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $52.20 | $4.18M | 0 |
BBIO Insiders
Similar Stocks to BBIO
MRNA
Moderna, Inc.
$225.82+1.80%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$969.36+4.43%
$83.15B
RVMD
Revolution Medicines, Inc.
$190.88-0.20%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$161.00-2.49%
$30.46B
UTHR
United Therapeutics Corporation
$595.67-0.51%
$25.15B
INCY
Incyte Corporation
$119.31-1.01%
$23.69B
INSM
Insmed Incorporated
$111.22-1.20%
$21.18B
EXEL
Exelixis, Inc.
$71.60+3.14%
$16.64B